GENN — Genesis Healthcare Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $985.03m
- $3.91bn
Annual cashflow statement for Genesis Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | R2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -118 | -959 | -372 | 7.47 | -103 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 49.7 | 828 | 179 | -12.8 | 117 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -125 | 8.05 | -5.41 | -125 | 194 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 68.4 | 120 | 18.6 | -7.17 | 316 |
Capital Expenditures | -201 | -64.1 | -51.2 | -654 | -263 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 189 | 112 | 63 | 267 | 229 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.8 | 47.6 | 11.9 | -387 | -33.5 |
Financing Cash Flow Items | -11.6 | -2.68 | -19.5 | 11.1 | 7.15 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -65.7 | -173 | 53.2 | 378 | -94.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.1 | -4.82 | 83.6 | -16.5 | 187 |